The bill amends existing Florida statutes to enhance the availability and definition of emergency opioid antagonists in public K-12 schools and postsecondary educational institutions. Specifically, it allows public schools to purchase, use, and maintain a supply of emergency opioid antagonists that meet specified criteria, rather than being limited to naloxone. The bill also revises the definition of "emergency opioid antagonist" to include any FDA-approved drug that blocks the effects of opioids, thereby broadening the scope of medications that can be utilized in emergency situations.

Additionally, the bill ensures that school district employees who administer these emergency opioid antagonists in compliance with relevant statutes are granted immunity from civil liability. The changes aim to improve the response to opioid overdoses in educational settings, thereby enhancing student safety. The act is set to take effect on July 1, 2025.

Statutes affected:
H 355 Filed: 1002.20, 1004.0971